4,850,000
TB incidence in 2022
170,000
drug-resistant TB incidence in 2022
99,000
TB cases in people with HIV in 2022
The Union's work in South-East Asia
Project Axshya Plus
In collaboration with local partners and over 15,000 community volunteers, The Union provided innovative tuberculosis (TB) interventions designed to serve traditionally hard-to-reach and at-risk populations in India.
Integrated HIV Care Programme - Myanmar
Through its Integrated HIV Care (IHC) Programme, The Union Office in Myanmar currently provides services to nearly 34,000 People Living with HIV, more than 33,400 of which are taking antiretroviral treatment.
The Union's Offices
The Union South-East Asia Office was The Union’s first region office, located in India. The Union Office in Myanmar located in Mandalay provides HIV and TB-HIV programmes.
The Union Office in India
C-6, Qutub Institutional Area
110016 New Delhi
India
Phone: (+91) 11 46 054 400
Phone: (+91) 11 46 054 430 / 429
The Union Office in Myanmar
Ma-39/25-26, 52nd Street, between 42nd & 43rd Street, Maha Aung Myay
Mandalay, Myanmar
Phone: (+95) 9 409 973 377
Phone: (+95) 9 944 973 377
Members of The Union South-East Asia Region
The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues.
The Union South-East Asia Region is made up of organisational and individual members.
UNION NEWS FROM THE South-East ASIA REGION
Conflation of prediction and causality in the TB literature
A forthcoming IJTLD OPEN article addresses the frequent conflation of prediction and causal inference in observational TB studies, and outlines practical recommendations to enhance research precision and transparency.
The rationale for cancer to be made a notifiable disease in India
In this Short Communication (to be published in the Q2 issue of PHA), the authors explain why the Ministry of Health in India should make cancer a notifiable disease.
Evaluating disability, comorbidities and risk factors after TB treatment: an 18–24 month follow-up in China
Ahead of World TB Day, we present an article that assesses disability, comorbidities and risk factors after TB treatment in China.
TB disability and multimorbidity at the onset of treatment in Kenya, Uganda, Zambia and Zimbabwe
Ahead of World TB Day, we present an article that assesses the burden of multimorbidity and the effectiveness of referral pathways at the start of TB treatment across Kenya, Uganda, Zambia and Zimbabwe